Cargando…

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents and accounts for approximately 2% of soft tissue sarcomas in adults. It is subcategorized into distinct subtypes based on histological features and fusion status (PAX-FOXO1/VGLL2/NCOA2). Despite advances in our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dehner, Carina A., Armstrong, Amy E., Yohe, Marielle, Shern, Jack F., Hirbe, Angela C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535289/ https://www.ncbi.nlm.nih.gov/pubmed/34680895 http://dx.doi.org/10.3390/genes12101500

Ejemplares similares

PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma
por: Hanna, J A, et al.
Publicado: (2016)

Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions
por: Kawamata, Norihiko, et al.
Publicado: (2011)

Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
por: Anderson, J, et al.
Publicado: (2001)

Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining
por: Zhan, Xiaohui, et al.
Publicado: (2023)

Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements
por: Vicente-García, Cristina, et al.
Publicado: (2017)

PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma
por: Akaike, Keisuke, et al.
Publicado: (2018)

Negative correlation of single-cell PAX3:FOXO1 expression with tumorigenicity in rhabdomyosarcoma
por: Regina, Carla, et al.
Publicado: (2021)

The PAX3-FOXO1 Fusion Protein Present in Rhabdomyosarcoma Interferes with Normal FOXO Activity and the TGF-β Pathway
por: Schmitt-Ney, Michel, et al.
Publicado: (2015)

JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
por: Walters, Zoë S, et al.
Publicado: (2013)

Structural and Functional Studies of FKHR-PAX3, a Reciprocal Fusion Gene of the t(2;13) Chromosomal Translocation in Alveolar Rhabdomyosarcoma
por: Hu, Qiande, et al.
Publicado: (2013)

Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon
por: Meyer, Anders, et al.
Publicado: (2023)

The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
por: Placzkowski, Kimberly A., et al.
Publicado: (2008)

Alveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis
por: Marshall, Amy D, et al.
Publicado: (2012)

Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma
por: AHN, EUN HYUN, et al.
Publicado: (2013)

PAX5 fusion genes in acute lymphoblastic leukemia: A literature review
por: Fouad, Fatma Mohamed, et al.
Publicado: (2023)

PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells
por: Tiffin, N, et al.
Publicado: (2003)

FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
por: Milewski, David, et al.
Publicado: (2021)

UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
por: Hardy, Laura R., et al.
Publicado: (2018)

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors
por: Searcy, Madeline B., et al.
Publicado: (2023)

KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1‐driven and independent disease‐promoting gene expression in fusion‐positive Rhabdomyosarcoma
por: Sobral, Lays M., et al.
Publicado: (2020)

Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis
por: Kuang, Shihuan, et al.
Publicado: (2006)

PAX7, PAX9 and RYK Expression in Cleft Affected Tissue
por: Vaivads, Mārtiņš, et al.
Publicado: (2021)

The regenerative potential of Pax3/Pax7 on skeletal muscle injury
por: Azhar, Muhamad, et al.
Publicado: (2022)

Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein
por: Nabarro, Stephen, et al.
Publicado: (2005)

Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma
por: Nguyen, Thanh Hung, et al.
Publicado: (2018)

Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
por: Langdon, Casey G., et al.
Publicado: (2021)

MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells
por: Cassandri, Matteo, et al.
Publicado: (2021)

Progression and Differentiation of Alveolar Rhabdomyosarcoma Is Regulated by PAX7 Transcription Factor—Significance of Tumor Subclones
por: Skrzypek, Klaudia, et al.
Publicado: (2021)

Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR–dependent motility in alveolar rhabdomyosarcoma cells
por: Liu, Lingling, et al.
Publicado: (2012)

Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2021)

The BioPAX Validator
por: Rodchenkov, Igor, et al.
Publicado: (2013)

Pax7 is back
por: Brack, Andrew S
Publicado: (2014)

Clonality and Evolutionary History of Rhabdomyosarcoma
por: Chen, Li, et al.
Publicado: (2015)

Pax2 and Pax8 cooperate in mouse inner ear morphogenesis and innervation
por: Bouchard, Maxime, et al.
Publicado: (2010)

Characterization of Zebrafish Pax1b and Pax9 in Fin Bud Development
por: Chen, Xuemei, et al.
Publicado: (2014)

Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein
por: Zhang, Yanxiao, et al.
Publicado: (2015)

Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity
por: Nakazawa, Kay, et al.
Publicado: (2023)

Pax3 loss of function delays tumour progression in kRAS-induced zebrafish rhabdomyosarcoma models
por: Kahsay, A., et al.
Publicado: (2022)

Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations
por: Hart, Matthew R., et al.
Publicado: (2018)

PaxA, but not PaxC, is required for cnidocyte development in the sea anemone Nematostella vectensis
por: Babonis, Leslie S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9thl4qmc4ntl2mal4ccjnikiv7